National burden and risk factors of diabetes mellitus in China from 1990 to 2021: Results from the Global Burden of Disease study 2021

被引:7
作者
Deng, Wenzhen [1 ,2 ]
Zhao, Li [1 ,2 ]
Chen, Cheng [2 ]
Ren, Ziyu [1 ]
Jing, Yuanyuan [1 ]
Qiu, Jingwen [1 ]
Liu, Dongfang [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, 74 Linjiang Rd, Chongqing 400010, Peoples R China
[2] Qianjiang Cent Hosp Chongqing, Dept Endocrinol, Qianjiang, Peoples R China
关键词
diabetes mellitus; disability-adjusted life years; global disease burden; incidence; prevalence; INSULIN-RESISTANCE; INTENSITY EXERCISE; BODY-MASS; TYPE-2; EPIDEMIOLOGY; PREVENTION; PREVALENCE; OBESITY; METAANALYSIS; MORTALITY;
D O I
10.1111/1753-0407.70012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundIn recent years, the prevalence and mortality rates of diabetes have been rising continuously, posing a significant threat to public health and placing a heavy burden on the population. This study was conducted to describe and analyze the burden of diabetes in China from 1990 to 2021 and its attributable risk factors.MethodsUtilizing data from the Global Burden of Disease Study 2021, we analyzed the incidence, prevalence, and disability-adjusted life years (DALYs) of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) in China from 1990 to 2021. We extracted sex- and age-specific data on diabetes, focusing on DALYs, years lived with disability, and years of life lost. Bayesian meta-regression and spatiotemporal Gaussian process regression were used to estimate disease parameters. Age-standardized rates (ASRs) and estimated annual percentage changes (EAPC) were calculated using direct standardization and log-linear regression. The population-attributable fractions were also determined for each risk factor.ResultsIn 2021, the absolute number of incident diabetes mellitus (DM) cases was estimated at 4003543.82, including 32 000 T1DM and 3971486.24 T2DM cases. The ASRs were 244.57 for DM, 2.67 for T1DM, and 241.9 for T2DM (per 100 000 population). The absolute number of prevalent DM cases was 117288553.93, including 1442775.09 T1DM and 115845778.84 T2DM cases. The ASRs were 6142.29 for DM, 86.78 for T1DM, and 6055.51 for T2DM (per 100 000 population). In 2021, there were 178475.73 deaths caused by DM, with an ASR of mortality of 8.98 per 100 000 population. The DALYs due to DM in 2021 were 11713613.86, with an ASR of 585.43 per 100 000 population and an EAPC of 0.57. This increase can be attributed to several factors, including high body mass index, air pollution, and dietary habits.ConclusionsThe burden of diabetes is considerable, with high prevalence and incidence rates, highlighting the urgent need for public health interventions. Addressing factors like high fasting plasma glucose, body mass index, air pollution, and dietary risks through effective interventions is critical. imageConclusionsThe burden of diabetes is considerable, with high prevalence and incidence rates, highlighting the urgent need for public health interventions. Addressing factors like high fasting plasma glucose, body mass index, air pollution, and dietary risks through effective interventions is critical. image HighlightsThe incidence, prevalence, and DALYs rate of diabetes in China are at relatively high levels, with a severe and rapidly growing burden of disability, particularly prominent among males. Interventions should be strengthened for major factors contributing to the diabetes burden, including high fasting plasma glucose, high body mass index, air pollution, and dietary risks. image
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Cervical cancer burden and attributable risk factors across different age and regions from 1990 to 2021 and future burden prediction: results from the global burden of disease study 2021
    Cheng, Lu-yao
    Zhao, Ji-qi
    Zou, Ting-ting
    Xu, Zhong-hua
    Lv, Yin
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [22] Trends and projections of the burden of disease for male infertility in China from 1990 to 2021: an analysis from the Global Burden of Disease 2021 study
    Xu, Ran
    Wang, Xin-jun
    Lin, Qing-cheng
    Zhuang, Yan-ting
    Zhou, Qing-ying
    Xu, Nai-fen
    Zheng, Ding-qin
    FRONTIERS IN REPRODUCTIVE HEALTH, 2024, 6
  • [23] Global, regional, and national burden of preterm birth, 1990-2021:-2021: a systematic analysis from the global burden of disease study 2021
    Liang, Xifeng
    Lyu, Yaning
    Li, Jing
    Li, Yu
    Chi, Cheng
    ECLINICALMEDICINE, 2024, 76
  • [24] Global, regional, and national burden of chronic kidney disease due to diabetes mellitus type 2 from 1990 to 2021, with projections to 2036: a systematic analysis for the Global Burden of Disease Study 2021
    Hu, Ruikang
    Zhao, Zhifeng
    Xie, Luze
    Ma, Zhenjie
    Wu, Wen
    Li, Shuangxi
    FRONTIERS IN MEDICINE, 2025, 12
  • [25] Global burden of atrial fibrillation attributable to high body mass index from 1990 to 2021: findings from the Global Burden of Disease Study 2021
    Kong, Xiangmeng
    Wang, Mingliang
    Jiang, Yumei
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [26] Global, regional and national epidemiological trends of multiple myeloma from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021
    Zhuge, Linmin
    Lin, Xiaowu
    Fan, Ziwei
    Jia, Mengxian
    Lin, Chaowei
    Zhu, Minyu
    Teng, Honglin
    Chen, Guoliang
    FRONTIERS IN PUBLIC HEALTH, 2025, 13
  • [27] The burden of Gastric Cancer and possible risk factors from 1990 to 2021, and projections until 2035: findings from the Global Burden of Disease Study 2021
    Qin, Niping
    Fan, Yangyan
    Yang, Tao
    Yang, Zhiping
    Fan, Daiming
    BIOMARKER RESEARCH, 2025, 13 (01)
  • [28] Burden of alopecia areata in China, 1990-2021: Global Burden of Disease Study 2021
    Li Xiangqian
    Liu Huixin
    Ren Wenhui
    Zhu Qijiong
    Yin Peng
    Wang Lijun
    Zhang Jianzhong
    Qi Jinlei
    Zhou Cheng
    中华医学杂志英文版, 2025, 138 (03)
  • [29] Burden of alopecia areata in China, 1990-2021: Global Burden of Disease Study 2021
    Li, Xiangqian
    Liu, Huixin
    Ren, Wenhui
    Zhu, Qijiong
    Yin, Peng
    Wang, Lijun
    Zhang, Jianzhong
    Qi, Jinlei
    Zhou, Cheng
    CHINESE MEDICAL JOURNAL, 2025, 138 (03) : 318 - 324
  • [30] The burden of type 2 diabetes in China from 1990 to 2021: A comparative analysis with G20 countries using the global burden of disease study 2021
    An, Kang
    Zhang, Jinyi
    Wang, Xingyou
    Qiao, Runjuan
    An, Zhenmei
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 224